Hathaway has over 20 years of experience in intellectual property matters. She focuses on the areas of life sciences, especially in the fields of immunology, biochemistry, pharmacogenomics, proteomics, and disease biomarkers, and their application to personalized medicine. Hathaway has developed world-wide patent strategies to protect drug products in the market with multi-billion annual sales, and she has conducted IP due diligence for multiple multi-million dollar transactions. She collaborates with the firm's Government Strategies Group on regulatory matters, including initiatives by the FDA in the area of advanced diagnostics. She also works with the Litigation Group and has filed amicus briefs in the U.S. Supreme Court in numerous cases including Mayo Collaborative Services and Mayo Clinic Rochester v. Prometheus Laboratories, Inc.
In addition to her practice, Hathaway has lectured on patenting strategies at national and international conferences. She is an active member of the American Intellectual Property Law Association (AIPLA) and has played a significant role in advancing AIPLA’sWomen in IP Committee.